MARAMAI, SAMUELE
 Distribuzione geografica
Continente #
EU - Europa 2.912
NA - Nord America 2.574
AS - Asia 1.423
SA - Sud America 267
AF - Africa 27
OC - Oceania 2
Totale 7.205
Nazione #
US - Stati Uniti d'America 2.525
IT - Italia 705
RU - Federazione Russa 654
GB - Regno Unito 513
CN - Cina 487
SG - Singapore 433
IE - Irlanda 261
DE - Germania 229
BR - Brasile 214
SE - Svezia 136
HK - Hong Kong 123
KR - Corea 116
FI - Finlandia 110
UA - Ucraina 97
FR - Francia 88
IN - India 74
VN - Vietnam 69
TR - Turchia 36
CA - Canada 29
ES - Italia 25
AR - Argentina 24
AT - Austria 20
JP - Giappone 19
NL - Olanda 17
MX - Messico 15
EC - Ecuador 14
ID - Indonesia 12
BD - Bangladesh 10
CZ - Repubblica Ceca 10
BE - Belgio 9
PL - Polonia 8
EG - Egitto 7
IQ - Iraq 7
CI - Costa d'Avorio 6
CO - Colombia 6
ZA - Sudafrica 6
PK - Pakistan 5
HU - Ungheria 4
IR - Iran 4
LT - Lituania 4
PT - Portogallo 4
RO - Romania 4
IL - Israele 3
JO - Giordania 3
RS - Serbia 3
TN - Tunisia 3
AM - Armenia 2
AU - Australia 2
AZ - Azerbaigian 2
EE - Estonia 2
GY - Guiana 2
JM - Giamaica 2
LK - Sri Lanka 2
MA - Marocco 2
PE - Perù 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
PY - Paraguay 1
TH - Thailandia 1
TJ - Tagikistan 1
UY - Uruguay 1
Totale 7.205
Città #
Dallas 533
Southend 435
Singapore 295
Dublin 258
Fairfield 213
Siena 202
Ashburn 186
Moscow 164
Chandler 150
Hefei 139
Santa Clara 139
Hong Kong 122
Munich 121
Seoul 114
Beijing 100
Woodbridge 97
Wilmington 91
Milan 90
Seattle 89
Ann Arbor 81
Florence 80
Houston 80
Jacksonville 74
Helsinki 72
Cambridge 68
Los Angeles 57
New York 54
Bengaluru 35
Princeton 33
Nanjing 27
Izmir 26
Shanghai 26
Dearborn 25
Rome 24
Boardman 23
Ho Chi Minh City 19
São Paulo 18
Buffalo 17
San Diego 17
The Dalles 17
Tokyo 17
Vienna 15
London 14
Hanoi 13
Bari 12
Fremont 12
Columbus 11
Lappeenranta 11
Redondo Beach 11
Rio de Janeiro 11
Toronto 11
Amsterdam 10
Chicago 10
Düsseldorf 10
Nuremberg 10
Parma 10
San Mateo 10
Turku 10
Washington 10
Brussels 9
Council Bluffs 9
Frankfurt am Main 9
L’Aquila 9
Mogliano 9
Brno 8
Brooklyn 8
Guangzhou 8
Guayaquil 8
San Francisco 8
Aligarh 7
Lancaster 7
Málaga 7
Nanchang 7
Naples 7
Stockholm 7
Warsaw 7
Abidjan 6
Bologna 6
Boston 6
Charlotte 6
Da Nang 6
Jakarta 6
Jiaxing 6
Jinan 6
Montreal 6
Phoenix 6
Salt Lake City 6
Shenyang 6
Belo Horizonte 5
Cairo 5
Dhaka 5
Hebei 5
Johannesburg 5
Kunming 5
Lauterbourg 5
Maisons-Alfort 5
Menlo Park 5
Mexico City 5
Norwalk 5
Perugia 5
Totale 4.895
Nome #
(S)-2-Amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)propanoic Acid (AMPA) and Kainate Receptor Ligands: further exploration of bioisosteric replacements and structural and biological investigation 403
Development of novel cyclic peptides as pro-apoptotic agents 368
Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain 350
Activation of the Wnt pathway by small peptides: rational design, synthesis and biological evaluation 301
Development of Potent Inhibitors of Fatty Acid Amide Hydrolase Useful for the Treatment of Neuropathic Pain 290
Novel analgesic/anti-inflammatory agents: 1,5-Diarylpyrrole nitrooxyethyl sulfides and related compounds as Cyclooxygenase-2 inhibitors containing a nitric oxide donor moiety endowed with vasorelaxant properties 288
A stereoselective approach to peptidomimetic BACE1 inhibitors 269
Harnessing the role of HDAC6 in Idiopathic Pulmonary Fibrosis: design, synthesis, structural analysis, and biological evaluation of potent inhibitors 250
Dopamine D3 receptor antagonists as potential therapeutics for the treatment of neurological diseases 246
Discovery of Potent Inhibitors of Human and Mouse Fatty Acid Amide Hydrolases 246
Design, synthesis and biological evaluation of light-driven on-off multitarget AChE and MAO-B inhibitors 244
Selective Kainate Receptor (GluK1) Ligands Structurally Based upon 1H-Cyclopentapyrimidin-2,4(1H,3H)-dione: Synthesis, Molecular Modeling, and Pharmacological and Biostructural Characterization 218
Disease modifying anti-Alzheimer’s drugs: inhibitors of human cholinesterases interfering with β-amyloid aggregation 211
Identification of a novel arylpiperazine scaffold for fatty acid amide hydrolase inhibition with improved drug disposition properties 191
Multifunctional Cholinesterase and Amyloid Beta Fibrillization Modulators. Synthesis and Biological Investigation 189
2-Hydroxy-5-(3,5,7-trihydroxy-4-oxo-4H-chromen-2-yl)phenyl(E)-3-(4-hydroxy-3-methoxyphenyl)acrylate: synthesis, in silico analysis and in vitro pharmacological evaluation 187
In Silico-Guided Rational Drug Design and Synthesis of Novel 4-(Thiophen-2-yl)butanamides as Potent and Selective TRPV1 Agonists 186
Harnessing the pyrroloquinoxaline scaffold for FAAH and MAGL interaction: definition of the structural determinants for enzyme inhibition 184
An Intramolecular Hydroaminomethylation-Based Approach to Pyrrolizidine Alkaloids under Microwave-Assisted Heating 183
Phenylpyrrole-based HDAC inhibitors: synthesis, molecular modeling and biological studies 164
Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. SARs, Structural Analysis, and Biological Characterization 162
Quinolines and Oxazino-quinoline derivatives as small molecule GLI1 inhibitors identified by virtual screening 158
Catechol-O-methyltransferase (COMT) 149
Micellar catalysis for sustainable hydroformylation 141
Exploiting the bile acid binding protein as transporter of a Cholic Acid/Mirin bioconjugate for potential applications in liver cancer therapy 137
CHAPTER 18: Microwave Irradiation 134
Development of a practical and scalable route for the preparation of the deacetoxytubuvaline (dTuv) fragment of pretubulysin and analogs 132
Novel multitarget directed ligands inspired by riluzole: A serendipitous synthesis of substituted benzo[b][1,4]thiazepines potentially useful as neuroprotective agents 130
Light-mediated activation/deactivation control and in vitro ADME-Tox profiling of a donepezil-like Dual AChE/MAO-B Inhibitor 129
Lipoic/Capsaicin-Related Amides: Synthesis and Biological Characterization of New TRPV1 Agonists Endowed with Protective Properties against Oxidative Stress 126
Use of imidazo[1,5-a]quinoline scaffold as the pharmacophore in the design of bivalent ligands of central benzodiazepine receptors 126
Structural characterization of human heat shock protein 90 N-Terminal domain and its variants K112R and K112A in complex with a potent 1,2,3-Triazole-based inhibitor 119
null 109
Subtype selective γ-Aminobutyric scid type A receptor (GABAAR) modulators acting at the benzodiazepine binding site: an update 108
Macroreticular POLITAG-Pd(0) for the waste minimized hydrogenation/reductive amination of phenols using formic acid as hydrogen source 104
Indole-2-Carboxamide as an Effective Scaffold for the Design of New TRPV1 Agonists 101
Inhibition of monoacylglycerol lipase by NSD1819 as an effective strategy for the endocannabinoid system modulation against neuroinflammation-related disorders 86
Multitarget therapeutic strategies for Alzheimer's disease: review on emerging target combinations 62
Multitarget-directed ligands for neurodegenerative diseases: real opportunity or blurry mirage? 60
Therapeutic potential for coxib-nitric oxide releasing hybrids in cancer treatment 55
Targeting endocannabinoid metabolism: an arrow with multiple tips against multiple sclerosis 45
Evaluation of a New Riluzole‐Based Compound VA945 on Sodium and Potassium Conductances Expressed by SH-SY5Y-Derived Neurons 17
Drug enteric metabolism in gut microbiota-brain crosstalk 3
Totale 7.361
Categoria #
all - tutte 20.761
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.761


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021318 0 0 0 0 0 79 17 57 31 83 31 20
2021/2022439 39 48 44 45 16 15 31 21 20 45 48 67
2022/2023587 23 43 74 72 72 122 28 54 62 18 12 7
2023/2024670 50 24 70 42 49 135 150 10 11 23 22 84
2024/20251.560 61 51 149 95 140 98 130 103 142 86 134 371
2025/20262.434 299 520 463 490 615 47 0 0 0 0 0 0
Totale 7.361